The effect of disuse on cholinergic enzymes.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 1282511)

Published in J Physiol on January 01, 1978

Authors

I J Butler, D B Drachman, A M Goldberg

Articles cited by this

Pharmacological modifications of the sodium channels of frog nerve. J Gen Physiol (1968) 9.97

A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem (1975) 4.29

Synthesis, storage and release of [14C]acetylcholine in isolated rat diaphragm muscles. J Physiol (1970) 3.80

Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem J (1969) 2.36

ACETYLCHOLINE AND CHOLINE ACETYLTRANSFERASE IN THE DIAPHRAGM OF THE RAT. J Physiol (1964) 2.34

Increase in tyrosine hydroxylase activity after reserpine administration. J Pharmacol Exp Ther (1969) 2.32

Changes in contractile properties of disused soleus muscles. J Physiol (1969) 2.09

MICRODETERMINATION OF CHOLINE ACETYLASE IN NERVOUS TISSUE. J Neurochem (1965) 1.73

Effect of muscle disuse on acetylcholine receptors. Nature (1976) 1.25

Choline acetyltransferase activity is increased in combined cultures of spinal cord and muscle cells from mice. Science (1973) 1.19

Trans-synaptic enzyme induction. Life Sci (1974) 1.11

Velocity and intensity of bidirectional migration of acetylcholinesterase in transected nerves. Brain Res (1971) 1.11

Acetylcholinesterase at the myoneural junction: cytochemical ultrastructure and some biochemical considerations. J Histochem Cytochem (1972) 1.02

Neurotrophic regulation of muscle cholinesterase: effects of botulinum toxin and denervation. J Physiol (1972) 1.01

Induction of cholinergic enzymes in chick ciliary ganglion and iris muscle cells during synapse formation. J Physiol (1976) 0.95

Observations on the expected decrease in proprioceptive discharge and purported advent of non-proprioceptive activity from the chronically tenotomized muscle. Brain Res (1973) 0.95

Electrotonic processing of information by brain cells. Science (1976) 0.95

Recent developments in biochemical investigations of cholinergic transmission. Brain Res (1973) 0.92

Increased activity of the peripheral sympathetic nervous system: induction of choline acetyltransferase in the preganglionic cholinergic neurone. Nature (1973) 0.88

Transport, turnover and distribution of choline acetyltransferase and acetylcholinesterase in the vagus and hypoglossal nerves of the rabbit. J Neurochem (1973) 0.88

Adaptation of the adrenal medulla: sustained increase in choline acetyltransferase by psychosocial stimulation. Science (1972) 0.87

Proceedings: Delayed increase in tyrosine hydroxylase activity in rat superior cervical ganglion after electrical stimulation of the preganglionic nerve. J Physiol (1975) 0.84

Transport of proteins, glycoproteins and cholinergic enzymes in regenerating hypoglossal neurons. J Neurochem (1974) 0.84

Choline acetyltransferase and acetylcholinesterase in myo-tendinous and neuro-muscular junctions of mouse skeletal muscle. Experientia (1970) 0.80

The relationship of choline acetyltransferase activity at the neuromuscular junction to changes in muscle mass and function. J Physiol (1974) 0.80

Effects of neuromuscular activity on choline acetyltransferase and acetylcholinesterase. Exp Neurol (1973) 0.79

Choline acetyltransferase and cholinesterase activities in muscle of dystrophic mice. Am J Physiol (1967) 0.79

The use of local anaesthetics to produce prolonged motor nerve block in the study of denervation hypersensitivity. Pflugers Arch (1975) 0.78

Transport of choline acetyltransferase and acetylcholinesterase in the rat sciatic nerve: a biochemical and electron histochemical study. J Neurochem (1973) 0.78

Effects of castration, testosterone and immobilization on the activities of choline acetyltransferase and cholinesterase in rat limb muscles. J Neurol Sci (1976) 0.77

Transport and changes of activity of choline acetyltransferase in the peripheral stump of an interrupted nerve. Brain Res (1974) 0.77

Articles by these authors

(truncated to the top 100)

Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science (1973) 2.86

Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol (1990) 2.66

Multifocal motor neuropathy: response to human immune globulin. Ann Neurol (1993) 2.32

Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N Engl J Med (1977) 2.23

Botulinum toxin: mechanism of presynaptic blockade. Science (1976) 2.19

Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet (1998) 2.17

Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med (1978) 2.15

"Myopathic" changes in chronically denervated muscle. Arch Neurol (1967) 2.01

Myasthenic immunoglobulin accelerates acetylcholine receptor degradation. Science (1977) 1.91

Dopaminergic dsyfunction in Tourette syndrome. Ann Neurol (1982) 1.79

Trophic regulation of acetylcholine sensitivity of muscle: effect of electrical stimulation. Science (1972) 1.77

Myasthenia gravis (first of two parts). N Engl J Med (1978) 1.74

Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment. N Engl J Med (1974) 1.71

Prednisone in Duchenne muscular dystrophy. Lancet (1974) 1.65

The determination of picomole amounts of acetylcholine in mammalian brain. J Neurochem (1973) 1.51

The role of movement in the development of joints and related structures: the head and neck in the chick embryo. J Embryol Exp Morphol (1969) 1.48

Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med (1982) 1.45

Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain (2003) 1.40

Persistent unilateral tibialis anterior muscle hypertrophy with complex repetitive discharges and myalgia: report of two unique cases and response to botulinum toxin. Neurology (1992) 1.39

Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis. Science (1977) 1.36

Lead-induced behavioral dysfunction: an animal model of hyperactivity. Exp Neurol (1974) 1.32

Control of acetylcholine synthesis--the inhibition of choline acetyltransferase by acetylcholine. J Neurochem (1969) 1.29

Neurological deterioration in adult phenylketonuria. J Inherit Metab Dis (1989) 1.28

Rapid-onset dystonia-parkinsonism. Neurology (1993) 1.26

Reduction of biogenic amine levels in the Rett syndrome. N Engl J Med (1985) 1.26

A new stain for quantitative measurement of sprouting at neuromuscular junctions. Muscle Nerve (1979) 1.26

Effect of muscle disuse on acetylcholine receptors. Nature (1976) 1.25

Extended cervicomediastinal thymectomy in the integrated management of myasthenia gravis. Ann Surg (1997) 1.24

Effect of myasthenic immunoglobulin on acetylcholine receptors of intact mammalian neuromuscular junctions. Science (1978) 1.22

Diencephalic syndrome revisited. J Pediatr (1976) 1.21

Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. N Engl J Med (1977) 1.20

Effects of aging on nerve sprouting and regeneration. Exp Neurol (1980) 1.17

Myasthenia gravis (second of two parts). N Engl J Med (1978) 1.16

Binding affinities of anti-acetylcholine receptor autoantibodies in myasthenia gravis. J Immunol (1982) 1.16

Ocular pseudomyasthenia or ocular myasthenia 'plus': a warning to clinicians. Neurology (1989) 1.16

Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology (1988) 1.16

Trophic functions of the neuron. 3. Mechanisms of neurotrophic interactions. The role of acetylcholine as a neurotropic transmitter. Ann N Y Acad Sci (1974) 1.13

Long-term treatment of juvenile Huntington's chorea with dipropylacetic acid. Neurology (1977) 1.13

Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology (2001) 1.12

The three Rs: the way forward. Environ Health Perspect (1996) 1.11

Motor nerve sprouting and acetylcholine receptors. Science (1978) 1.11

Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process. Proc Natl Acad Sci U S A (1978) 1.10

Variable phenotype of rapid-onset dystonia-parkinsonism. Mov Disord (1996) 1.09

Identical mitochondrial DNA deletion in blood and muscle. Lancet (1989) 1.09

Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis. Ann Neurol (1994) 1.07

Myeloma neuropathy. Successful treatment of two patients and review of cases. Arch Neurol (1972) 1.05

The pathogenesis of reactive axonal swellings: role of axonal transport. J Neuropathol Exp Neurol (1977) 1.05

Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit. Arch Neurol (1987) 1.05

Denervation accelerates the degradation of junctional acetylcholine receptors. Exp Neurol (1981) 1.03

Subtle consequences of methylmercury exposure: behavioral deviations in offspring of treated mothers. Science (1972) 1.03

Neurological basis of respiratory complications in achondroplasia. Ann Neurol (1988) 1.02

Neurotrophic regulation of muscle cholinesterase: effects of botulinum toxin and denervation. J Physiol (1972) 1.01

Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome. Ann Neurol (1989) 1.01

Neurotransmission regulates stability of acetylcholine receptors at the neuromuscular junction. J Neurosci (1989) 1.00

Long-term neurological sequelae in achondroplasia. Eur J Pediatr (1984) 1.00

Botulinum toxin blocks quantal but not non-quantal release of ACh at the neuromuscular junction. Brain Res (1983) 0.98

Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters. Ann Neurol (1988) 0.98

Neurologic morbidity associated with achondroplasia. J Child Neurol (1990) 0.97

Mechanisms of acetylcholine receptor loss in myasthenia gravis. J Neurol Neurosurg Psychiatry (1980) 0.97

Neurologic and psychiatric manifestations in a family with a mutation in exon 2 of the guanosine triphosphate-cyclohydrolase gene. Arch Neurol (2001) 0.97

Effect of botulinum toxin on trophic regulation of acetylcholine receptors. Nature (1977) 0.96

Fast axonal transport in motor nerve regeneration. J Neurobiol (1976) 0.96

Neurotransmitter defects and treatment of disorders of hyperphenylalaninemia. J Pediatr (1981) 0.96

Measurement of junctional acetylcholine receptors in myasthenia gravis: clinical correlates. Muscle Nerve (1985) 0.96

Cholinergic transmission regulates extrajunctional acetylcholine receptors. Exp Neurol (1980) 0.96

Impaired axonal regeneration in acrylamide intoxication. J Neurobiol (1977) 0.96

Blockade of acetylcholine receptors: a model of myasthenia gravis. Science (1975) 0.95

Computerized tomography of the foramen magnum: achondroplastic values compared to normal standards. Am J Med Genet (1985) 0.95

Neurotrophic regulation of two properties of skeletal muscle by impulse-dependent and spontaneous acetylcholine transmission. J Neurosci (1982) 0.95

Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J Clin Invest (1989) 0.95

Incorporation of axonally transported glycoproteins into axolemma during nerve regeneration. J Cell Biol (1981) 0.94

Treatment of experimental myasthenia gravis with cyclosporin A. Clin Immunol Immunopathol (1985) 0.94

Microdetermination of choline acetyltransferase--a comparison of reinecke vs. periodide precipitation. J Neurochem (1969) 0.93

Myasthenia gravis as a receptor disorder. Ann N Y Acad Sci (1976) 0.92

The biology of myasthenia gravis. Annu Rev Neurosci (1981) 0.92

Hyperactivity: a lead-induced behavior disorder. Environ Health Perspect (1974) 0.92

Congenital hypomyelinating neuropathy. J Neurol Neurosurg Psychiatry (1985) 0.91

Pharmacological and neurochemical investigations of lead-induced hyperactivity. Neuropharmacology (1975) 0.91

Myasthenic patients' IgG causes redistribution of acetylcholine receptors: freeze-fracture studies. J Neurosci (1983) 0.91

Calcium transport in isolated sarcoplasmic reticulum during muscle maturation. Nature (1968) 0.91

Isaacs syndrome with laryngeal involvement: an unusual presentation of myokymia. Neurology (1979) 0.91

Combined immunodeficiency and vaccine-related poliomyelitis in a child with cartilage-hair hypoplasia. J Pediatr (1975) 0.91

Rapid-onset dystonia-parkinsonism: a report of clinical, biochemical, and genetic studies in two families. Adv Neurol (1998) 0.91

Sphenoid sinusitis masquerading as migraine headaches in children. J Child Neurol (2001) 0.91

Aromatic L-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a second family. J Child Neurol (1997) 0.90

Short-latency somatosensory evoked potentials in the management of patients with achondroplasia. Neurology (1984) 0.90

Combined short-term immunotherapy for experimental autoimmune myasthenia gravis. Ann Neurol (1983) 0.90

Encephalopathy associated with respiratory syncytial virus bronchiolitis. J Child Neurol (2001) 0.89

Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid. Ann Neurol (1980) 0.89

A disorder of biogenic amines in dihydropteridine reductase deficiency. Ann Neurol (1978) 0.89

Heteroplasmy in chronic external ophthalmoplegia: clinical and molecular observations. Pediatr Res (1990) 0.88

Pharmacological denervation of skeletal muscle in chick embryos treated with botulinum toxin. Trans Am Neurol Assoc (1965) 0.88

Membrane myopathy: morphological similarities to Duchenne muscular dystrophy. Muscle Nerve (1982) 0.88

Biogenic amine metabolism in Tourette syndrome. Ann Neurol (1979) 0.88

Regeneration in botulinum-poisoned forelimbs of the newt, Triturus. Exp Neurol (1971) 0.87

Treatment of ongoing experimental myasthenia gravis with short term high dose cyclophosphamide. Muscle Nerve (1982) 0.87

Immunotherapy of experimental autoimmune myasthenia gravis: selective effects of CTLA4Ig and synergistic combination with an IL2-diphtheria toxin fusion protein. J Neuroimmunol (1998) 0.87

Adaptation of the adrenal medulla: sustained increase in choline acetyltransferase by psychosocial stimulation. Science (1972) 0.87

Rolandic type cerebral palsy in children as a pattern of hypoxic-ischemic injury in the full-term neonate. J Child Neurol (1998) 0.87

Excitatory amino acids in amyotrophic lateral sclerosis: an update. Ann Neurol (1991) 0.86